Analysis of pathogenic bacteria distribution and drug resistance of cervical site infection in gynecological malignant tumor patients
Objective To investigate the pathogenic bacteria distribution and drug resistance of cervical site infection in gynecological malignant tumor patients,and to provide reference for clinical drug use and cervical infection prevention.Methods The clinical data of 124 patients with gynecological malignant tumor were analyzed retrospectively.The cervical infection situation was analyzed,and clinical isolates were collected to analyze the distribution and drug resistance of pathogenic bacteria in cervical site infection.Results In 124 cases of gynecological malignant tumor,33 cases of cervical site infection were detected,and the cervical infection rate was 26.61％.Among the gram-positive cocci in patients with cervical infection of gynecological malignant tumors,the main one was Enterococcus faecalis,which had the highest resistance rate to erythromycin,and the other main ones were tetracycline,ciprofloxacin,levofloxacin and high concentration gentamicin.Among gram-negative bacteria,Escherichia coli had the highest drug resistance rate,followed by Klebsiella pneumoniae and Pseudomonas aeruginosa.Conclusion Patients with gynecological malignant tumors not only have a high infection rate in the cervical area,but also have severe drug resistance.Therefore,when preventing and treating infections,it is necessary to fully consider the characteristics of multiple microbial infections and their resistance,and strengthen the management of multidrug-resistant bacteria.
Gynecological malignancyCervical site infectionDrug resistance
万方数据
维普
